471 related articles for article (PubMed ID: 17622940)
1. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
2. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
[TBL] [Abstract][Full Text] [Related]
3. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
4. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
5. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
6. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
7. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
Tan XL; Popanda O; Ambrosone CB; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Chang-Claude J
Breast Cancer Res Treat; 2006 Jun; 97(3):255-62. PubMed ID: 16331344
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
[TBL] [Abstract][Full Text] [Related]
10. Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic.
Naccarati A; Pardini B; Polakova V; Smerhovsky Z; Vodickova L; Soucek P; Vrana D; Holcatova I; Ryska M; Vodicka P
Carcinogenesis; 2010 Apr; 31(4):666-70. PubMed ID: 20110284
[TBL] [Abstract][Full Text] [Related]
11. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma.
Gong Z; Hebert JR; Bostick RM; Deng Z; Hurley TG; Dixon DA; Nitcheva D; Xie D
Cancer; 2007 Mar; 109(5):849-57. PubMed ID: 17236225
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.
Cox DG; Pontes C; Guino E; Navarro M; Osorio A; Canzian F; Moreno V;
Br J Cancer; 2004 Jul; 91(2):339-43. PubMed ID: 15173859
[TBL] [Abstract][Full Text] [Related]
13. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic.
Pardini B; Naccarati A; Novotny J; Smerhovsky Z; Vodickova L; Polakova V; Hanova M; Slyskova J; Tulupova E; Kumar R; Bortlik M; Barale R; Hemminki K; Vodicka P
Mutat Res; 2008 Feb; 638(1-2):146-53. PubMed ID: 17991492
[TBL] [Abstract][Full Text] [Related]
14. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer.
Vogel U; Christensen J; Dybdahl M; Friis S; Hansen RD; Wallin H; Nexø BA; Raaschou-Nielsen O; Andersen PS; Overvad K; Tjønneland A
Mutat Res; 2007 Nov; 624(1-2):88-100. PubMed ID: 17544013
[TBL] [Abstract][Full Text] [Related]
18. Death receptor 4 variants and colorectal cancer risk.
Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
[TBL] [Abstract][Full Text] [Related]
19. O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).
Tranah GJ; Bugni J; Giovannucci E; Ma J; Fuchs C; Hines L; Samson L; Hunter DJ
Cancer Causes Control; 2006 Jun; 17(5):721-31. PubMed ID: 16633920
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]